1-2 of 2
Keywords: Myeloma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intermediate Dose of Intravenous Melphalan in Advanced Multiple Myeloma

Available to Purchase
Subject Area:
Oncology
S. Tsakanikas, K. Papanastasiou, M. Stamatelou, A. Maniatis
Journal: Oncology
Oncology (1991) 48 (5): 369–371.
https://doi.org/10.1159/000226961
Published Online: 26 June 2009
...S. Tsakanikas; K. Papanastasiou; M. Stamatelou; A. Maniatis Eighteen patients with advanced multiple myeloma resistant to VAD chemotherapy (vincristine, Adriamycin, dexamethasone) were treated with intravenous melphalan in a single-pulse dose of 50–70 mg/m 2 . Objective response (≥50% reduction...
View articletitled, Intermediate Dose of Intravenous Melphalan in Advanced Multiple Myeloma
Open the PDF for Intermediate Dose of Intravenous Melphalan in Advanced Multiple Myeloma in another window
Journal Articles

Combination Chemotherapy for Multiple Myeloma with BCNU, Cyclophosphamide, Vincristine, Melphalan, and Prednisone (M-2 Protocol)

Available to Purchase
Subject Area:
Oncology
D.C. Case, Jr., H.L. Sonneborn, S.D. Paul, D.M. Hayes, B.M. Dorsk, R.J. Carroll, L. Bove
Journal: Oncology
Oncology (1985) 42 (3): 137–140.
https://doi.org/10.1159/000226019
Published Online: 17 June 2009
...D.C. Case, Jr.; H.L. Sonneborn; S.D. Paul; D.M. Hayes; B.M. Dorsk; R.J. Carroll; L. Bove 54 consecutively referred, previously untreated patients with stage II and III multiple myeloma have been treated with the M-2 protocol. 50% of patients had a performance status of < 50%. 13% were stage II...
View articletitled, Combination Chemotherapy for Multiple Myeloma with BCNU, Cyclophosphamide, Vincristine, Melphalan, and Prednisone (M-2 Protocol)
Open the PDF for Combination Chemotherapy for Multiple Myeloma with BCNU, Cyclophosphamide, Vincristine, Melphalan, and Prednisone (M-2 Protocol) in another window